Roessingh Research and Development
Enschede, Overijssel, 7522AH, Netherlands
NCT Number: NCT05421910
Robotic training can be used to provide intensive training during the (early phases of) rehabilitation of a stroke. ROBERT®-SAS training is designed to create an active and intensive training tool for the rehabilitation of the lower extremity of stroke patients. Currently this has only be tested in a lab-based setting, which showed that is was feasible and could be executed while still being comfortable for the patient. The next step will be implementing the device in a clinical setting. Therefore, aims the current study to assess the feasibility of ROBERT®-SAS training in clinical setting, in acute stroke patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Enschede, Overijssel, 7522AH, Netherlands
Rationale: Stroke is one of the leading causes of disability of adults in the European Union. Around 80% of stroke survivors experience deficits in motor control, resulting in problems with keeping balance and walking, for instance. The extent and amount of deficits differ per individual. Interventions to train the lower extremity almost always consist of walking exercises. However, patients in the acute phase or with severely affected lower extremity function are often unable to walk or to walk independently. Therefore, the combination of a robot (ROBERT®) and functional electrical stimulation (ES) is being developed to provide a training tool for early rehabilitation. In the current study a combination of robot and ES will be evaluated in clinical setting.
Objective: The primary objective of the current study is to assess the feasibility of ROBERT®-SAS training in clinical setting, in acute stroke patients, including patient and therapist perspectives.
Study design: The current study is an observational study.
Study population: In the current study ten (sub) acute stroke patient will be included, with severely affected lower extremity. Five of these ten will be included as soon as possible after arrival at the rehabilitation centre. Another five will be included 3-5 weeks after arrival/start of the rehabilitation.
Main study parameters/endpoints: The main outcome parameter is the SUS score from both the patients and the therapists.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The current study consists of several measurement sessions in Roessingh Rehabilitation Centre, during the normal rehabilitation time. The robot, ROBERT® is CE-certified. However, the combination ROBERT®-SAS, combining both ES and robot support, is not, although previous tests have shown this approach is possible and tolerable by healthy persons and stroke patients. The risks are regarded as minimal because it is without invasive procedures, with room for rest in between trial sets as required by the participant, and application of individual stimulation profiles to not exceed tolerance levels or inflict pain during electrostimulation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Active training of movements in supine position. Movements such as knee extension and ankle dorsal flexion.
Time frame: 15 minutes
The System Usability Scale of patients and therapists. 10 questions with a 5-point response scale. The total score can range from 0 - 100, in which a higher score indicates a better usability
Time frame: 30 minutes
Surface EMG of the muscle that will be stimulated with electrical stimulation, expressed in volt.
Time frame: 30 minutes
Resulting force measured with the robot, expressed in kg
Time frame: 30 minutes
As a settings of the stimulation expressed in Hertz
Time frame: 30 minutes
The trajectory completion rate for the different stages of AAN. (different types of assistance). There are three different types, no assistance, electrical stimulation assistance and an combination of electrical stimulation and robot support.
Time frame: 10 minutes
Lower extremity module, to assess leg function. Scores can range between 0 and 28, in which a higher score indicates a higher leg function.
Time frame: 10 minutes
Lower extremity part, to assess the leg function. Scored for Ankle, knee and hip separately between 0 - 33 in which zero is know movement and 33 is normal movement. Total score can range between 0 - 99. (summation of the three joints)
Time frame: 5 minutes
To assess the walking capabilities, score between 0 and 5, in which 5 indicates a better walking capability.
Time frame: 30 minutes
Type of movement that will be trained during the measurements. Can be knee extension or ankle dorsal flexion with electrical stimulation.
Time frame: 15 minutes
Questions about their experience with ROBERT for all stakeholders. Open questions which will not have a score, but will be interpreted on question level.
Time frame: 30 minutes
As a settings of the stimulation expressed in milliseconds
Time frame: 30 Minutes
As a settings of the stimulation expressed in milliampere
Time frame: 30 minutes
The amount of repetitions during one set of a specific movement.
Time frame: 30 minutes
The amount of resistance during the training, can be changed during a set if necessary. The resistance can differ between 0-10, in which 10 is the heaviest.
Time frame: 1 minutes
gender will be noted as subject characteristic
Time frame: 1 minutes
Age will be noted as subject characteristic in years
Time frame: 1 minutes
time science stroke will be noted as subject characteristic in months
Time frame: 1 minutes
Weight will be noted as subject characteristic and used for BMI calculation, noted in kg
Time frame: 1 minutes
Height will be noted as subject characteristic and used for BMI calculation, noted in meters
Time frame: 1 minutes
The affected side will be used as subject characteristic
Roessingh Research and Development
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details